Skip Navigation


Annals of Oncology Advance Access first published online on July 21, 2009
This version published online on July 24, 2009
Annals of Oncology, doi:10.1093/annonc/mdp280
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mdp280v2    most recent
mdp280v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Lurje, G.
Right arrow Articles by Lenz, H.-J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lurje, G.
Right arrow Articles by Lenz, H.-J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org

Genetic variations in angiogenesis pathway genes associated with clinical outcome in localized gastric adenocarcinoma

G. Lurje1,{dagger}, H. Husain1,{dagger}, D. G. Power2, D. Yang3, S. Groshen3, A. Pohl1, W. Zhang1, Y. Ning1, P. C. Manegold1, A. El-Khoueiry1, S. Iqbal1, L. H. Tang4, M. A. Shah2 and H.-J. Lenz1,3,*

1 Division of Medical Oncology, Keck School of Medicine, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA
2 Gastrointestinal Oncology Service, Memorial Sloan-Kettering Cancer Center, Cornell University, New York, NY
3 Department of Preventive Medicine, Keck School of Medicine, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA
4 Department of Pathology, Memorial Sloan-Kettering Cancer Center, Cornell University, New York, NY, USA

* Correspondence to: Dr. H.-J. Lenz, Division of Medical Oncology, Keck School of Medicine, Norris Comprehensive Cancer Center, University of Southern California, 1441 Eastlake Avenue, Los Angeles, CA 90033, USA. Tel: +1-323-865-3967; Fax: +1-323-865-0061; E-mail: lenz{at}usc.edu

Background: Angiogenesis has been attributed to be a well-recognized aspect of human cancer biology. As such, proteinase-activated receptor (PAR)-1, endostatin (ES) and interleukin-8 (IL-8) mediate the regulation of early-onset angiogenesis and in turn impact the process of tumor-growth and disease progression.

Patients and methods: Formalin-fixed paraffin-embedded tissues were obtained from 137 patients with localized gastric cancer at University of Southern California and Memorial Sloan-Kettering Cancer Center medical facilities. DNA was extracted and genotyping was carried out using PCR–restriction fragment length polymorphism-based protocols.

Results: In false discovery rate-adjusted univariate analysis, PAR-1 –506 ins/del (P < 0.001), ES +4349 G>A (P = 0.004), and IL-8 –251 T>A (P < 0.0001) were associated with time to tumor recurrence (TTR). Further, PAR-1 –506 ins/del and IL-8 –251 were associated with overall survival (OS). After adjusting for covariates, IL-8 remained significantly associated with TTR (adjusted P = 0.003) and OS (adjusted P = 0.049), whereas ES was significantly associated with TTR (adjusted P = 0.026).

Conclusions: Polymorphisms in PAR-1, ES, and IL-8 may serve as independent molecular prognostic markers in patients with localized gastric adenocarcinoma. The assessment of the patients’ individual risk on the basis of interindividual genotypes may therefore help to identify patient subgroups at high risk for poor clinical outcome.

angiogenesis, gastric adenocarcinoma, IL-8, PAR-1, tumor recurrence

{dagger} Both authors contributed equally to this work. Presented in part at the 44th Annual Meeting of the American Society of Cilnical Onocology, Chicago, IL, May 30-June 3 (Abstract ID: 4559)

The name of the corresponding author has been corrected.

Received for publication December 4, 2008. Revision received April 13, 2009. Accepted for publication April 15, 2009.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.